Investigation of bioavailability and pharmacokinetics of treosulfan capsules in patients with relaps...
Investigation of bioavailability and pharmacokinetics of treosulfan capsules in patients with relapsed ovarian cancer
About this item
Full title
Author / Creator
Publisher
Berlin: Springer
Journal title
Language
English
Formats
Publication information
Publisher
Berlin: Springer
Subjects
More information
Scope and Contents
Contents
Treosulfan (L-threitol-1,4-bis-methanesulfonate, Ovastat) is a prodrug of a bifunctional alkylating agent with activity in ovarian carcinoma and other solid tumors. In a pharmacologic study of the bioavailability of treosulfan in a capsule formulation, patients with relapsed ovarian carcinoma were treated with alternating doses of oral and intraven...
Alternative Titles
Full title
Investigation of bioavailability and pharmacokinetics of treosulfan capsules in patients with relapsed ovarian cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmed_primary_10854136
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_10854136
Other Identifiers
ISSN
0344-5704
E-ISSN
1432-0843
DOI
10.1007/s002800051023
